Tech Company Financing Transactions
Ocera Therapeutics Funding Round
Oxford Finance and Silicon Valley Bank joined a $20 million funding round for Ocera Therapeutics. This VC investment round was announced on 8/3/2015.
Transaction Overview
Company Name
Announced On
8/3/2015
Transaction Type
Debt
Amount
$20,000,000
Round
Undisclosed
Investors
Oxford Finance (Christopher Herr)
Silicon Valley Bank (Jennifer Goldstein)
Proceeds Purpose
Ocera intends to use the capital to support development of its OCR-002 molecule to treat acute and chronic patients with hepatic encephalopathy.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
525 University Avenue 610
Palo Alto, CA 94301
USA
Palo Alto, CA 94301
USA
Phone
Website
Email Address
Overview
Ocera Therapeutics Inc. founded in January 2005, is a privately held, clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for gastrointestinal and liver diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Linda Grais
Chief Financial Officer
Michael Byrnes
VP - Sales
Gaurav Aggarwal
Browse more venture capital transactions:
Prev: 8/3/2015: GovX venture capital transaction
Next: 8/4/2015: Seriously venture capital transaction
Share this article
About Our VC Transactions Data
We report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs